These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 24953398

  • 1. Apolipoprotein B and apolipopotein A-I in vascular risk prediction - a review.
    Schmidt C, Bergstrom G.
    Curr Pharm Des; 2014; 20(40):6289-98. PubMed ID: 24953398
    [Abstract] [Full Text] [Related]

  • 2. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD.
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [Abstract] [Full Text] [Related]

  • 3. Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy.
    Walldius G, Jungner I.
    Nutr Metab Cardiovasc Dis; 2007 Oct; 17(8):565-71. PubMed ID: 17631989
    [Abstract] [Full Text] [Related]

  • 4. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
    Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E.
    Lancet; 2001 Dec 15; 358(9298):2026-33. PubMed ID: 11755609
    [Abstract] [Full Text] [Related]

  • 5. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.
    Walldius G, Jungner I.
    J Intern Med; 2006 May 15; 259(5):493-519. PubMed ID: 16629855
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels.
    Jun JE, Choi YJ, Lee YH, Kim DJ, Park SW, Huh BW, Lee EJ, Jee SH, Hur KY, Choi SH, Huh KB.
    Korean J Intern Med; 2018 Jan 15; 33(1):138-147. PubMed ID: 29334727
    [Abstract] [Full Text] [Related]

  • 8. Association of Apolipoproteins B and A-1 With Markers of Vascular Health or Cardiovascular Events.
    Zhu YM, Verma S, Fung M, McQueen MJ, Anderson TJ, Lonn EM.
    Can J Cardiol; 2017 Oct 15; 33(10):1305-1311. PubMed ID: 28941609
    [Abstract] [Full Text] [Related]

  • 9. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BH, Dullaart RP, PREVEND Study Group.
    J Clin Lipidol; 2013 Oct 15; 7(1):56-64. PubMed ID: 23351584
    [Abstract] [Full Text] [Related]

  • 10. ApoB/apoA-I ratio is better than LDL-C in detecting cardiovascular risk.
    Carnevale Schianca GP, Pedrazzoli R, Onolfo S, Colli E, Cornetti E, Bergamasco L, Fra GP, Bartoli E.
    Nutr Metab Cardiovasc Dis; 2011 Jun 15; 21(6):406-11. PubMed ID: 20171854
    [Abstract] [Full Text] [Related]

  • 11. Levels of lipids and apolipoproteins in three cultures.
    Solhpour A, Parkhideh S, Sarrafzadegan N, Asgary S, Williams K, Jungner I, Aastveit A, Walldius G, Sniderman A.
    Atherosclerosis; 2009 Nov 15; 207(1):200-7. PubMed ID: 19766218
    [Abstract] [Full Text] [Related]

  • 12. Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults.
    Zheng S, Han T, Xu H, Zhou H, Ren X, Wu P, Zheng J, Wang L, Zhang M, Jiang Y, Chen Y, Qiu H, Liu W, Hu Y.
    BMJ Open; 2017 Jan 20; 7(1):e014038. PubMed ID: 28110289
    [Abstract] [Full Text] [Related]

  • 13. The strengths and limitations of the apoB/apoA-I ratio to predict the risk of vascular disease: a Hegelian analysis.
    Sniderman AD, Kiss RS.
    Curr Atheroscler Rep; 2007 Oct 20; 9(4):261-5. PubMed ID: 18173952
    [Abstract] [Full Text] [Related]

  • 14. The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity.
    Kaneva AM, Potolitsyna NN, Bojko ER, Odland JØ.
    Dis Markers; 2015 Oct 20; 2015():591454. PubMed ID: 25852220
    [Abstract] [Full Text] [Related]

  • 15. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
    Bae JC, Han JM, Kwon S, Jee JH, Yu TY, Lee MK, Kim JH.
    Atherosclerosis; 2016 Aug 20; 251():170-176. PubMed ID: 27341533
    [Abstract] [Full Text] [Related]

  • 16. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK, Lichtenstein AH, Barrett PH, Dolnikowski GG, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2004 Sep 20; 24(9):1703-7. PubMed ID: 15242863
    [Abstract] [Full Text] [Related]

  • 17. Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study.
    Oksala N, Seppälä I, Hernesniemi J, Lyytikäinen LP, Kähönen M, Mäkelä KM, Reunanen A, Jula A, Ala-Korpela M, Lehtimäki T.
    Ann Med; 2013 Mar 20; 45(2):141-8. PubMed ID: 22524251
    [Abstract] [Full Text] [Related]

  • 18. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
    Khadem-Ansari MH, Rasmi Y, Rahimi-Pour A, Jafarzadeh M.
    Singapore Med J; 2009 Jun 20; 50(6):610-3. PubMed ID: 19551315
    [Abstract] [Full Text] [Related]

  • 19. Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study.
    Bruno G, Merletti F, Biggeri A, Bargero G, Prina-Cerai S, Pagano G, Cavallo-Perin P.
    Diabetologia; 2006 May 20; 49(5):937-44. PubMed ID: 16525840
    [Abstract] [Full Text] [Related]

  • 20. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
    Erbel R, Lehmann N, Churzidse S, Möhlenkamp S, Moebus S, Mahabadi AA, Schmermund A, Stang A, Dragano N, Grönemeyer D, Seibel R, Kälsch H, Bauer M, Bröcker-Preuss M, Mann K, Jöckel KH, Heinz Nixdorf Recall Study Investigators.
    Atherosclerosis; 2013 Aug 20; 229(2):531-40. PubMed ID: 23701995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.